Leukapheresis
This graph shows the total number of publications written about "Leukapheresis" by people in the URMC Research Network by year, and whether "Leukapheresis" was a major or minor topic of these publication.
Below are the most recent publications written about "Leukapheresis" by people in Profiles.
-
Blumberg N, Heal JM, Gettings KF, Phipps RP, Masel D, Refaai MA, Kirkley SA, Fialkow LB. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion. 2010 Dec; 50(12):2738-44.
-
Miyamoto H, Okahisa T, Iwaki H, Murata M, Ito S, Nitta Y, Akutagawa M, Kinouchi Y, Ohnishi Y, Oto J, Nishimura M. Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics. Ther Apher Dial. 2007 Feb; 11(1):16-21.
-
Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 2004 Nov; 50(11):3580-90.
-
Marroquin CE, Westwood JA, Lapointe R, Mixon A, Wunderlich JR, Caron D, Rosenberg SA, Hwu P. Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells. J Immunother. 2002 May-Jun; 25(3):278-88.
-
Rios JA, Korones DN, Heal JM, Blumberg N. WBC-reduced blood transfusions and clinical outcome in children with acute lymphoid leukemia. Transfusion. 2001 Jul; 41(7):873-7.
-
Rosenzweig M, MacVittie TJ, Harper D, Hempel D, Glickman RL, Johnson RP, Farese AM, Whiting-Theobald N, Linton GF, Yamasaki G, Jordan CT, Malech HL. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood. 1999 Oct 1; 94(7):2271-86.
-
Koç ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G, Reece DE, Fox RM, Schupp JE, Tainer N, Lazarus HM. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant. 1998 Feb; 21(4):337-43.
-
Bar MH, Sznol M, Atkins MB, Ciobanu N, Micetich KC, Boldt DH, Margolin KA, Aronson FR, Rayner AA, Hawkins MJ, et al. Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells. J Clin Oncol. 1990 Jul; 8(7):1138-47.
-
Phillips GL, Reece DE, Lerner KG, Connors JM. Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease. Bone Marrow Transplant. 1990 Jul; 6(1):45-7.
-
Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 1985 Dec 5; 313(23):1485-92.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
